GlaxoSmithKline Faces Allegations in China

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Most Recent Videos

Buy Macau Names in March: Macquarie’s Le Cornu
55:28 - Jan. 30 -- Macquarie Investment Management Senior Portfolio Manager Sam Le Cornu discusses the stocks that he’s bullish on in the South Korean beauty industry, the Chinese insurance sector and the gaming industry with Bloomberg’s Stephen Engle, Yvonne Man, Angie Lau and Rishaad Salamat on “Asia Edge.”
  • Football Is Gaining Traction in Asia: Young
  • India Seeks $3.7B in Coal India Stake Sale
  • Disrupting the Beauty Industry: Go Inside Birchbox